Profil
Kelly Mabry currently works at Cellia Science, Inc., as Chief Executive Officer from 2022.
Postes actifs de Kelly Mabry
| Sociétés | Poste | Début |
|---|---|---|
Cellia Science, Inc.
 Cellia Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cellia Science, Inc. develops and commercializes blood cell analyzers that provide rapid, actionable blood cell counts at the point of care. The company was founded in 2021 and is based in Fayetteville, AR. Cellia Science's lead device provides neutrophil and platelet counts for chemotherapy patients at risk of neutropenia and thrombocytopenia, using label-free deep-UV imaging technology exclusively licensed from a third party. The technology will be applied to additional diseases with significant unmet need in the future. Kelly Mabry has been the CEO of the company since 2022. | Directeur Général | 01/02/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Cellia Science, Inc.
Cellia Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cellia Science, Inc. develops and commercializes blood cell analyzers that provide rapid, actionable blood cell counts at the point of care. The company was founded in 2021 and is based in Fayetteville, AR. Cellia Science's lead device provides neutrophil and platelet counts for chemotherapy patients at risk of neutropenia and thrombocytopenia, using label-free deep-UV imaging technology exclusively licensed from a third party. The technology will be applied to additional diseases with significant unmet need in the future. Kelly Mabry has been the CEO of the company since 2022. | Commercial Services |
